Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?

scientific article published on December 2016

Can We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11999-016-5187-3
P932PMC publication ID5339146
P698PubMed publication ID27909972

P50authorRikard WedinQ39184325
P2093author name stringJohn H Healey
Patrick J Boland
Jonathan A Forsberg
P2860cites workA systematic review of physicians' survival predictions in terminally ill cancer patientsQ24680291
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statementQ28082297
Estimating survival in patients with operable skeletal metastases: an application of a bayesian belief networkQ28744589
External validation of the Bayesian Estimated Tools for Survival (BETS) models in patients with surgically treated skeletal metastasesQ34457923
Decision curve analysis: a novel method for evaluating prediction modelsQ34581068
How do we estimate survival? External validation of a tool for survival estimation in patients with metastatic bone disease-decision analysis and comparison of three international patient populations.Q35638675
Treating metastatic disease: Which survival model is best suited for the clinic?Q36585894
Modern Palliative Treatments for Metastatic Bone Disease: Awareness of Advantages, Disadvantages, and GuidanceQ38491226
Use and misuse of the receiver operating characteristic curve in risk predictionQ40241086
Trends in the surgical treatment of pathologic proximal femur fractures among Musculoskeletal Tumor Society membersQ41899100
A revised scoring system for preoperative evaluation of metastatic spine tumor prognosisQ81310747
Can physicians accurately predict survival time in patients with metastatic cancer? Analysis of RTOG 97-14Q81547146
Prognostic factors and a scoring system for patients with skeletal metastasisQ81690849
P433issue4
P407language of work or nameEnglishQ1860
P304page(s)1252-1261
P577publication date2016-12-01
P1433published inClinical Orthopaedics and Related ResearchQ5133783
P1476titleCan We Estimate Short- and Intermediate-term Survival in Patients Undergoing Surgery for Metastatic Bone Disease?
P478volume475

Reverse relations

cites work (P2860)
Q58814145CORR Insights: Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
Q88662901CORR Insights®: External Validation and Optimization of the SPRING Model for Prediction of Survival After Surgical Treatment of Bone Metastases of the Extremities
Q90492183CORR Insights®: External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases
Q50183451CORR Insights®: Is Total Femur Replacement a Reliable Treatment Option for Patients With Metastatic Carcinoma of the Femur?
Q92339309CORR Insights®: What Are the Applications and Limitations of Artificial Intelligence for Fracture Detection and Classification in Orthopaedic Trauma Imaging? A Systematic Review
Q38755048Can A Multivariate Model for Survival Estimation in Skeletal Metastases (PATHFx) Be Externally Validated Using Japanese Patients?
Q57135867Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?
Q90338922Editorial: Threshold P Values in Orthopaedic Research-We Know the Problem. What is the Solution?
Q90492166External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases
Q96121873Validation of PATHFx 2.0-an open source tool for estimating survival in patients undergoing pathologic fracture fixation

Search more.